1.Childhood Brain Tumors.
Journal of the Korean Pediatric Society 2002;45(9):1055-1058
No abstract available.
Brain Neoplasms*
;
Brain*
2.Time to establish multidisciplinary childhood cancer survivorship programs in Korea.
Korean Journal of Hematology 2010;45(2):84-87
Improved treatment strategies and better supportive care have resulted in increased survival rates for childhood cancers. However, most of the survivors may have complex, long-term health issues. In 2004, Childhood Cancer Survivorship Study of the United States confirmed that both survivors and the medical community need to be educated about the late effects of childhood cancer treatment. Korea, with an estimated number of childhood cancer survivors of 20,000 to 25,000, faces similar challenges that the United States had experienced earlier. Despite of the tight budgetary situation on the part of government and hospitals, nationwide cohort study for Korean childhood cancer survivors was proposed and the versions of instruments to measure the quality of life of childhood cancer survivors were already validated. Nationwide registry of long-term survivors as well as the multi-center study is to be developed not only for the care of the survivors but also to raise the patient's awareness of the importance of regular follow-up. In addition to education of primary care providers regarding the survivorship, the need for special education program in the school system is emphasized.
Cohort Studies
;
Education, Special
;
Follow-Up Studies
;
Humans
;
Korea
;
Primary Health Care
;
Quality of Life
;
Survival Rate
;
Survivors
;
United States
3.Atypical Teratoid/Rhabdoid Tumor in Central Nervous System: Report of 2 Cases.
Jae Myung KIM ; Young Shin RA ; Thad T GHIM ; Shin Kwang KHANG
Journal of Korean Neurosurgical Society 2002;32(6):599-602
We report two cases of atypical teratoid/rhabdoid tumor(AT/RT) in the central nervous system. Primary central nervous system AT/RT is an extremely rare malignant tumor affecting infants and young children. These tumors have been diagnosed previously as primitive neuroectodermal tumors(PNETs) because AT/RT contains fields indistinguishable from classic PNETs. Separation of these two tumor types is crucial because the prognosis for AT/RT is poor even when treatment includes surgery with or without radiation therapy and/or chemotherapy. Clinical, radiological and histopathological features of AT/RT are presented.
Central Nervous System*
;
Child
;
Drug Therapy
;
Humans
;
Infant
;
Neural Plate
;
Neuroectodermal Tumors, Primitive
;
Prognosis
4.KSPNO Protocol for Glioma.
Byung Kyu CHO ; Hye Lim JUNG ; Thad T GHIM ; Il Han KIM ; Yong Kil HONG ; Young Shin RA ; Mee Jeong LEE
Korean Journal of Pediatric Hematology-Oncology 2005;12(2):244-285
No abstract available.
Glioma*
5.Normalization of Red Cell Enolase Level Following Allogeneic Bone Marrow Transplantation in a Child with Diamond-Blackfan Anemia.
Jeong A PARK ; Yeon Jung LIM ; Hyeon Jin PARK ; Sun Young KONG ; Byung Kiu PARK ; Thad T GHIM
Journal of Korean Medical Science 2010;25(4):626-629
We describe a girl with Diamond-Blackfan anemia with accompanying red cell enolase deficiency. At the age of 9 yr old, the patient received allogeneic bone marrow transplantation from her HLA-identical sister who had normal red cell enolase activity. While the post transplant DNA analysis with short tandem repeat has continuously demonstrated a stable mixed chimerism on follow-up, the patient remains transfusion independent and continues to show a steady increase in red cell enolase activity for over two and a half years following bone marrow transplantation.
*Anemia, Diamond-Blackfan/blood/enzymology/surgery
;
Bone Marrow Cells/cytology/metabolism
;
*Bone Marrow Transplantation
;
Child
;
Child, Preschool
;
Erythrocytes/*enzymology
;
Female
;
Humans
;
Infant
;
Phosphopyruvate Hydratase/genetics/*metabolism
;
*Transplantation, Homologous
6.A Case of Kaposiform Hemangio-Lymphangiomatosis.
Jun Eun PARK ; Jong Jin SEO ; Hyung Nam MOON ; Thad T GHIM
Korean Journal of Pediatric Hematology-Oncology 2000;7(2):287-292
Kaposiform hemangio-lymphangiomatosis is an extremely rare and locally aggressive vascular neoplasm. This neoplasm histologically shows dilated vascular spaces lined by flat endothelium-like cells and areas of spindle cells forming slit-like vascular spaces similar to those described in Kaposi's sarcoma. We report a case of this neoplasm which originated from the mediastinum infiltrating other adjacent soft tissues such as thymus and pulmonary interstitium without the evidence of distant metastasis. In spite of interferon-alpha2b therapy and excision of this neoplasm, the patient expired due to respiratory failure caused by aggravating interstitial pneumonia and progression of the neoplasm.
Hemangioma
;
Humans
;
Lung Diseases, Interstitial
;
Lymphangioma
;
Mediastinum
;
Neoplasm Metastasis
;
Respiratory Insufficiency
;
Sarcoma, Kaposi
;
Thymus Gland
;
Vascular Neoplasms
7.A Case of Posttransplant Lymphoproliferative Disease Following Renal Transplantation in a Child.
Won Kyoung JHANG ; Hyewon HAHN ; Mee Jeung LEE ; Young Seo PARK ; Thad T GHIM
Journal of the Korean Society of Pediatric Nephrology 2003;7(2):245-252
Posttransplant lymphoproliferative disease(PTLD) has emerged as a potential life-threatening complication of immunosuppressive therapy after organ transplantation. The occurrence of PTLD is usually associated with an Epstein-Barr virus(EBV) infection in patients who are treated by aggressive immunosuppressive therapy. PTLD is represented by diverse manifestations ranging from reactive lymphoid hyperplasia to high grade malignant lymphoma. This is a case report of a late PTLD in a child. The patient is a 14-year-old girl, who presented as malignant lymphoma 44 months after successful renal transplantation. There was no evidence of EBV infection. On bone marrow study, many neoplastic lymphoid cells were detected. Aggressive chemotherapy for PTLD had resulted in clinical remission. However the patient expired from uncontrolled sepsis and septic shock after 77 days.
Adolescent
;
Bone Marrow
;
Child*
;
Drug Therapy
;
Epstein-Barr Virus Infections
;
Female
;
Herpesvirus 4, Human
;
Humans
;
Kidney Transplantation*
;
Lymphocytes
;
Lymphoma
;
Organ Transplantation
;
Pseudolymphoma
;
Sepsis
;
Shock, Septic
;
Transplants
8.Treatment Outcome of Childhood B-cell Lymphoma and L3 Acute Lymphoblastic Leukemia from a Single Institution.
Yeon Jung LIM ; Yoon Jung KIM ; Joon Sup SONG ; Mi Jung LEE ; Jong Jin SEO ; Hyung Nam MOON ; Thad T GHIM
Korean Journal of Pediatric Hematology-Oncology 2005;12(1):28-39
PURPOSE: High survival rate can be obtained in B-cell lymphoma (Burkitt's lymphoma, diffuse large B-cell lymphoma) and L3 acute lymphoblastic leukemia (ALL) with multiagent chemotherapy. Objectives of this study were to evaluate the treatment outcomes of B-cell lymphoma and L3 ALL diagnosed at the Department of Pediatrics, Asan Medical Center. METHODS: The medical records of 32 children who were diagnosed with Burkitt's lymphoma, diffuse large B-cell lymphoma and L3 ALL from March 1992 to July 2004 at Asan Medical Center were reviewed retrospectively. The 5 year event free survival (EFS) according to the diagnosis, age, risk group and lactic dehydrogenase (LDH) level were analyzed. RESULTS: There were 23 boys and 9 girls. Age ranged from 9 months to 14.4 years old with a median of 7.1 years. Fourteen patients had L3 ALL, 11 had Burkitt's lymphoma and 7 had diffuse large B-cell lymphoma. Five patients (15.6%) had CNS involvement and 5 with B-cell lymphoma (27.8%, 5/18) had BM involvement. All patients who received appropriate chemotherapy achieved a complete remission (CR), but 18.8% (6/32) relapsed. Among 6 relapsed patients, 5 achieved CR after reinduction chemotherapy. One who had no response to secondary chemotherapy and 2 with isolated CNS relapse died due to disease progression. The most common treatment-related toxicity was myelosuppression (87.5%) followed by neutropenic fever (81.3%). Median follow up is 25 months (3 months to 74 months). Four patients who achieved CR after proper induction therapy (4/32, 12.5%) died, 3 due to relapse and 1 due to toxicity-related complication (neutropenia and sepsis). The 5 year EFS for all patients was 77.5+/-7.5% and the 5 year overall survival was 84.6+/-7.3%. The 5 year EFS of B-cell lymphoma compared with that of L3, ALL was 94.4+/-5.4% versus 55.1+/-13.9% (P=0.012) and 5 year overall survival of relapsed patients was 50.0+/-13.9%. CNS disease at diagnosis, age, LDH had no significant influence on EFS. CONCLUSION: High survival rate of childhood B-cell lymphomas and L3 ALL was obtained with recent intensive multiagent chemotherapy and about 50% of relapsed patients were salvaged with reinduction. High incidence of the treatment-related toxicity such as myelosuppression, neutropenic fever and TLS was observed, but the treatment-related mortality was very low with recent supportive therapies. Survival rate was improved with prompt and appropriate management for the treatment-related toxicity of the intensive chemotherapy.
B-Lymphocytes*
;
Burkitt Lymphoma
;
Central Nervous System Diseases
;
Child
;
Chungcheongnam-do
;
Diagnosis
;
Disease Progression
;
Disease-Free Survival
;
Drug Therapy
;
Female
;
Fever
;
Follow-Up Studies
;
Humans
;
Incidence
;
Lymphoma, B-Cell*
;
Lymphoma, Non-Hodgkin
;
Medical Records
;
Mortality
;
Oxidoreductases
;
Pediatrics
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
;
Recurrence
;
Retrospective Studies
;
Survival Rate
;
Treatment Outcome*
9.Primary Hepatic Tumors in Children: Clinical Experience in a Single Institution.
Hee Chul LEE ; Yoon Jeong KIM ; Jong Jin SEO ; Hyung Nam MOON ; Thad T GHIM
Korean Journal of Pediatric Hematology-Oncology 2000;7(2):269-277
PURPOSE: The frequency and clinical characteristics of primary childhood hepatic tumors diagnosed in a single institution were reviewed. Method: From January 1991 to June 2000, 33 patients were diagnosed with primary hepatic tumor. Retrospective analysis of the medical records of the various primary hepatic tumors was performed. RESULTS: Among the total of 33 patients with primary hepatic tumor, twenty five (76%) were malignant and eight (24%) were benign. The mean age of patients with hepatoblastoma (HB) was 32 months (12 of 16 patients were less than 3 years), 12.8 years in hepatocellular carcinoma (HCC) (all of them were older than 11 years), 2 months in hemangioendothelioma (HE), and 3 months in hamartoma. The ratio of male to female was 1:1 in HB, and 4:1 in HCC. The presence of hepatitis B infection was detected in 80% (4/5) of HCC and in 13% (2/16) of HB. The common presenting symptoms at diagnosis were the palpable mass, abdominal pain and jaundice. Many tumors were found incidentally without any presenting symptoms. Of 33 patients, 22 had involvement at right lobe. HCC had more necrosis and hemorrhage within the tumor than HB on imaging study. HE had a distinct feature of contrast enhancement increasing from the peripheral portion of the mass to central portion. Hamartoma showed a feature with multiple cysts and septums within the mass. To confirm the diagnosis, a tissue biopsy was done in 23 patients (70%). A significantly elevated level of serum alpha-fetoprotein (AFP) is found in 88% (mean 386,000 ng/mL) of HB cases and 100% (mean 369,000 ng/mL) of HCC. The mean AFP level in HB patients was 391,000 ng/mL at diagnosis, 52 ng/mL after the preoperative chemotherapy, 8.3 ng/mL at postoperative follow-up, and 2.8 ng/mL at completion of chemotherapy. In HCC, the AFP level decreased temporarily after chemotherapy or chemo- embolization, but increasesd at recurrence in most case. Patients resectable at the time of diagnosis or after preoperative chemotherapy were 12 (75%) in HB, and 10 of them are were alive with median the follow-up of 34 months (5 mo.~8 yrs 7 mo.). All the HCC patients were unresectable or had metastatic lesion at diagnosis, and all of them were assumed dead following discharge. Conclusions: Among the primary hepatic tumors in children, malignant tumors are more frequent than benign. Age of onset, AFP level and imaging studies all play an important role in diagnosis, and biopsy is usually confirmative. HCC has an extremely poor prognosis in childhood. HB patients with complete surgical resection enjoy a relatively high long term survival.
Abdominal Pain
;
Age of Onset
;
alpha-Fetoproteins
;
Biopsy
;
Carcinoma, Hepatocellular
;
Child*
;
Diagnosis
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Hamartoma
;
Hemangioendothelioma
;
Hemorrhage
;
Hepatitis B
;
Hepatoblastoma
;
Humans
;
Jaundice
;
Male
;
Medical Records
;
Necrosis
;
Prognosis
;
Recurrence
;
Retrospective Studies
10.Clinical Characteristics of Biphenotypic Acute Leukemia in Childhood: A Single Institutional Experience.
Mee Jeong LEE ; Jong Jin SEO ; Chan Jeoung PARK ; Hyun Sook CHI ; Hyung Nam MOON ; Thad T GHIM
Korean Journal of Pediatric Hematology-Oncology 2003;10(1):49-57
PURPOSE: The diagnostic criteria of the biphenotypic acute leukemia (BAL) are based on the number and degree of the specificity of the immunological markers expressed on the leukemic blasts. The newer diagnostic criteria proposed by The European Group for the Immunological Classification of Leukaemias (EGIL) is now well accepted. We have recently evaluated our BAL patients using the EGIL criteria and analyzed the clinical characteristics, treatment and clinical outcome. METHODS: Fourteen children diagnosed with BAL among 193 childhood acute leukemia patients in our hospital from January 1995 to December 2001 were retrospectively reviewed. RESULTS: The incidence of BAL was 7.3% (14 out of 193 cases). Of these 14 patients, 12 were de novo and 2 were secondary. In the de novo group, the immunological marker studies showed myeloid/B-lymphoid phenotype in 6 (50%), myeloid/T-lymphoid in 3 and B-lymphoid/T-lymphoid in 1. In addition, two patients showed trilineage differentiation. Cytogenetic analysis revealed various abnormal karyotypes in the majority of the cases, showing normal karyotype only in 3 cases. Among the karyotype abnormalities, two were t (9; 22) and one was t (4; 11). Chemotherapy was mostly based on the induction regimen of acute lymphoblastic leukemia therapy (12 of 14 cases). One patient was treated with acute myeloid leukemia regimen and one patient received combination of both acute lymphoid and myeloid regimen. Induction of complete remission was achieved in 100% of the patients and the median duration of induction therapy to complete remission was 33 days. Five of the 12 de novo patients died during the median follow-up of 16.5 months (4 months to 37.5 months) and the 2 year survival rate was only 52%. CONCLUSION: The incidence of BAL in children is relatively rare and the most common immunophenotypic expression consists of myeloid and B-lymphoid coexpression. Most of the cases showed chromosomal abnormalities. The outcome of BAL treated mostly with the traditional acute lymphoblastic leukemia induc without stem cell transplantation should be sought especially in those expressing poor prognostic cytogenetic abnormalities or strong myeloid marker expression.
Abnormal Karyotype
;
Child
;
Chromosome Aberrations
;
Classification
;
Cytogenetic Analysis
;
Drug Therapy
;
Follow-Up Studies
;
Humans
;
Incidence
;
Karyotype
;
Leukemia
;
Leukemia, Biphenotypic, Acute*
;
Leukemia, Myeloid, Acute
;
Phenotype
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
Retrospective Studies
;
Sensitivity and Specificity
;
Stem Cell Transplantation
;
Survival Rate